(Reuters) - Bio-Rad Laboratories cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients. Shares of the diagnostics ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Bio-Rad Laboratories on Thursday lowered its annual revenue growth forecast, given the uncertain pace of the biopharma ...
BIO-RAD LABORATORIES ($BIO) posted quarterly earnings results on Thursday, February 13th. The company reported earnings of $2.90 per share, beating estimates of $2.90 ...
On October 26, Bio-Rad Laboratories is presenting latest earnings. Analysts predict Bio-Rad Laboratories will report earnings per share of $2.78. Track Bio-Rad Laboratories stock price in real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results